Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/23/1993 | WO1993010102A1 Novel compounds having a guanidine structure and pharmaceutical composition containing same |
05/23/1993 | CA2101058A1 Novel compounds having a guanidine structure and pharmaceutical composition containing same |
05/22/1993 | CA2083359A1 Melatonin derivatives and combinations with antiestrogen compounds for treating mamalian breast carcinoma |
05/22/1993 | CA2083307A1 Aminoalkanephosphinic acids and salts thereof |
05/22/1993 | CA2083223A1 Local delivery of dipyridamole for the treatment of proliferative diseases |
05/22/1993 | CA2083109A1 Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods |
05/21/1993 | CA2083323A1 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses |
05/20/1993 | CA2081236A1 Amino acid derivatives |
05/19/1993 | WO1993010079A1 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them |
05/19/1993 | EP0542708A1 Substituted B-amino acid derivatives useful as platelet aggregation inhibitors |
05/19/1993 | EP0542689A1 Use of 1-(aminoalkyl)-3-quinoxaline-2-on derivatives for the preparation of neuroprotective compositions |
05/19/1993 | EP0542681A1 Process for the preparation of carbocyclic nucleosides and its intermediates |
05/19/1993 | EP0542671A1 Substituted hydroquinone derivatives as intermediates of benzofuran derivatives |
05/19/1993 | EP0542632A1 Use of beta-carotene in the treatment of asthma |
05/19/1993 | EP0542630A2 Use of derivatives of amphotericin B as protease inhibitors |
05/19/1993 | EP0542622A1 New lupane derivatives, a process for their production and pharmaceutical compositions containing them |
05/19/1993 | EP0542609A1 3-sulfonylamino-2-(1H)-quinolinones and 7-aza derivatives as excitatory amino acids antagonists |
05/19/1993 | EP0542565A1 Pharmacological stress testing for coronary artery disease |
05/19/1993 | EP0542554A1 Substituted N-biphenylyl lactams |
05/19/1993 | EP0542549A1 Use of cosmetic composition |
05/19/1993 | EP0542525A2 Antithrombotic agents |
05/19/1993 | EP0542468A1 Isothiazolyl compounds and their use as microbicides |
05/19/1993 | EP0542424A1 Oxytocin recepto and DNA coding for the same |
05/19/1993 | EP0542411A2 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation |
05/19/1993 | EP0542392A1 Use of thiol-S-(2-diethyl-aminoethyl)-ester compound for the preparation of a medicament for the treating neuro-muscular incontinence |
05/19/1993 | EP0542372A1 2-Substituted saccharin derivative proteolytic enzyme inhibitors |
05/19/1993 | EP0542371A1 Saccharin derivative proteolytic enzyme inhibitors |
05/19/1993 | EP0542364A1 Controlled release device |
05/19/1993 | EP0542363A2 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
05/19/1993 | EP0542355A1 Amorphous (Quinolin-2-ylmethoxy)indoles as leukotriene antagonists |
05/19/1993 | EP0542203A2 Fused benzeneoxyacetic acid derivatives as PGl2 receptor agonists |
05/19/1993 | EP0542145A1 Oligosaccharides with antigenic determinants from the jelly coat of amphibian eggs |
05/19/1993 | EP0542136A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
05/19/1993 | EP0542059A1 Substituted biphenylpyridinones as angiotensin II antagonists |
05/19/1993 | EP0541874A1 Compositions containing diosmin |
05/19/1993 | EP0541802A1 Diphenylmethylpiperazine derivative |
05/19/1993 | EP0541798A1 New diamine compound and brain protecting agent containing the same |
05/19/1993 | EP0541757A1 NEW HETERO-ARYLOXY-$g(b)-CARBOLINES, THEIR PREPARATION AND THEIR USE IN MEDICAMENTS |
05/19/1993 | EP0541742A1 2',5'-nucleotide analogs as antiviral agents |
05/19/1993 | EP0541737A1 N-phenyl-cinnamamides providing protection from the harmful effects of ultraviolet light. |
05/19/1993 | EP0541722A1 Compounds and methods for inhibiting gene expression. |
05/19/1993 | EP0541720A1 Golfomycin derivatives: novel fused ring cyclodecadiyne derivatives |
05/19/1993 | EP0541719A1 New carbohydrate-based anti-inflammatory agents |
05/19/1993 | EP0541706A1 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids. |
05/19/1993 | EP0541705A1 Substituted 1h-imidazol-5-yl]alkanoic acids |
05/19/1993 | EP0541692A1 Herpes simplex virus vp16 vaccines |
05/19/1993 | EP0541670A1 Phosphene oxide-terminated allene-ene-yne dna-cleaving, antitumor and antibiotic molecules |
05/19/1993 | EP0541634A1 1,4-dihydropyridine derivatives |
05/19/1993 | EP0541597A1 Hexa-n-(o-hydroxybenzyl) neomycin b for inhibiting human retroviruses and for the treatment of aids |
05/19/1993 | EP0541594A1 Cyclopentane derivatives, process for producing them and their pharmaceutical use. |
05/19/1993 | EP0541593A1 Cyclopentane derivatives, process for producing them and their pharmaceutical use. |
05/19/1993 | EP0541550A1 New intermediates, their production and use. |
05/19/1993 | EP0541524A1 Food and feedstuff. |
05/19/1993 | EP0408713B1 Phenylsulphone derivatives |
05/19/1993 | EP0407410B1 Antidiabetic 3-halo-beta-aminoestranes |
05/19/1993 | DE4137812A1 New 1-(1,4-bi:phenyl-methyl) benzimidazole(s) as angiotensin II antagonists |
05/19/1993 | CN1072183A Method for extracting bufalin and use of bufalin and related derivative |
05/19/1993 | CN1072182A Preparation process for 20-0x0-17alpha, 21-dihydroxylated derivatives of pregnane and intermediates |
05/19/1993 | CN1072180A Substituted biphenylpyridones |
05/19/1993 | CN1072176A Butyric acid derivatives |
05/19/1993 | CN1072173A Therapeutic agents |
05/19/1993 | CN1072172A Novel t-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
05/19/1993 | CN1072093A Nitroglycerine adhesive plaster and process for preparing same |
05/19/1993 | CN1072061A Stable antimicrobial dialdehyde composition and methods of use |
05/19/1993 | CN1020732C Preparation method for substituted vinylcephalosporins. |
05/19/1993 | CN1020730C Preparing method for thiazolketone additive |
05/19/1993 | CN1020723C Process for 4-phenyl-4-(n-(phenyl) amido) piperidine derivatives |
05/19/1993 | CA2100338A1 Non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them |
05/19/1993 | CA2082839A1 Pharmaceutical compounds |
05/18/1993 | US5212324 Treatment of cataract with 15-keto-prostaglandin compounds |
05/18/1993 | US5212323 Process for producing 6-(3-dimethylaminopropionyl)forskolin |
05/18/1993 | US5212204 Release nitric acid |
05/18/1993 | US5212202 Alkyl ester |
05/18/1993 | US5212201 Xanthine oxidase inhibitor |
05/18/1993 | US5212200 Prostaglandins |
05/18/1993 | US5212196 Imidazole compound |
05/18/1993 | US5212195 Substituted indole antagonists derivatives which are angiotensin II |
05/18/1993 | US5212188 Method for treatment of neurodegenerative diseases |
05/18/1993 | US5212187 Pyridyl alkylamine compounds which are useful against histamine h1 and h2 receptors |
05/18/1993 | US5212186 Cardioactive pyrrolobenzimidazoles |
05/18/1993 | US5212185 Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
05/18/1993 | US5212181 Cerebral disorders |
05/18/1993 | US5212178 Compounds for treatment of Parkinson*s Disease |
05/18/1993 | US5212177 Indole and benzimidazole-substituted dihydropyrimidine derivatives |
05/18/1993 | US5212176 Adrenergic blockers |
05/18/1993 | US5212173 Alkylaminoalkylamine and ether compounds, processes and intermediates for their preparation, and medicaments containing them |
05/18/1993 | US5212169 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating pain |
05/18/1993 | US5212168 Corticosteriod, beta adrenergic agent |
05/18/1993 | US5212167 Modulation of receptor-mediated ion transport |
05/18/1993 | US5212166 Antiandrogens or 5-alpha reductase inhibitors |
05/18/1993 | US5212165 Enzyme inhibitor |
05/18/1993 | US5212161 Antitumor |
05/18/1993 | US5212160 Autoimmune disease, aging or bronchopulmonary disease |
05/18/1993 | US5212155 Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
05/18/1993 | US5211958 Tetracycline with cellulose derivatives as thickeners and tablets |
05/18/1993 | US5211957 Diclofenac |
05/18/1993 | US5211956 Pharmaceutical compositions containing phytic acid or its salts |
05/18/1993 | US5211955 Pharmaceutical composition containing a hydrophilic active compound, treated with an organic acid and encapsulated in a liposome |
05/18/1993 | US5211954 Low dose temazepam |
05/18/1993 | US5211953 Liver function improver |